Lancet Gastroenterology & Hepatology, 7, 388-390 Méndez-Sánchez, N, Bugianesi, E, Gish, R G, Lammert, F, Tilg, H, Nguyen, M H, Sarin, S K, Fabrellas, N, Zelber-Sagi, S, Fan, J-G, Shiha, G, Targher, G, Zheng, M-H, Chan, W-K, Vinker, S, Kawaguchi, T, Castera, L, Yilmaz, Y, Korenjak, M, Spearman, C W, Ungan, M, Palmer, M, El-Shabrawi, M, Gruss, H-J, Dufour, J-F, Dhawan, A, Wedemeyer, H, George, J, Valenti, L, Fouad, Y, Romero-Gomez, M, Eslam, M & Global multi-stakeholder consensus on the redefinition of fatty liver disease 2022, ' Global multi-stakeholder endorsement of the MAFLD definition ', The Lancet. Gastroenterology & hepatology, vol. 7, no. 5, pp. 388-390 . https://doi.org/10.1016/S2468-1253(22)00062-0 The Lancet Gastroenterology & hepatology, Vol. 7, no.5, p. 388-390 (2022) Lancet gastroenterology & hepatology Lancet Gastroenterology & Hepatology, 7, 5, pp. 388-390